ArticleDiscover oncology2026
CircTMCC1 enhances radioresistance in esophageal squamous cell carcinoma by upregulating MYC via miR-186-3p sponging.
Article in Discover oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The involvement of circRNA in the radiosensitivity of various malignancies has been well established; however, its specific regulatory function and underlying mechanisms in esophageal squamous cell carcinoma (ESCC) radiosensitivity remain largely unexplored. In this study, differentially expressed circRNAs were identified in ESCC tissues and cells exhibiting either radiosensitivity or resistance. Notably, circTMCC1 was found to be upregulated in radioresistant ESCC tissues and was predominantly localized in the cytoplasm. In both in vivo and in vitro models, silencing of circTMCC1 enhanced the radiosensitivity of ESCC cells. Mechanistic investigations further demonstrated that circTMCC1 acts as a molecular sponge for miR-186-3p, thereby promoting MYC expression and contributing to radioresistance in ESCC. This study identifies a novel role for the circTMCC1/miR-186-3p/MYC axis in regulating radioresistance in ESCC, suggesting the potential for new therapeutic strategies in ESCC radiotherapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.